BioSpace News Archive

Press Releases

Ivonescimab Shows Quality of Life Benefits in Chemotherapy-Free First-Line NSCLC: Health-Related Quality of Life Data from the HARMONi-2 Study Presented at ELCC 2026

March 31, 2026

·

6 min read

Press Releases

SignateraTM MRD Identifies Breast Cancer Patients Who Can Forgo Surgery

March 31, 2026

·

3 min read

ransparent plastic tube being blocked by orange balls on blue background. Illustration of the concept of digestive disorders and difficulties on career paths

Cardiovascular disease

Merck’s Cholesterol Pill Delivers ‘Antibody-Like Efficacy’ After Earning FDA Voucher

Merck is eyeing a quick review for its lipid-lowering drug candidate enlicitide, which in December was awarded a Commissioner’s National Priority Voucher.

March 31, 2026

·

2 min read

·

Tristan Manalac

Stagflation, economic slow down or recession while inflation high up, GDP growth decrease causing by unemployment concept, fearful businessman riding fall down economic graph with inflation high up.

Immunology and inflammation

Viridian Turns Red as Thyroid Eye Disease Data Disappoint

Despite hitting its primary endpoint, Viridian’s thyroid eye disease antibody failed to ease eye bulging to the degree that analysts had been hoping for, and the biotech’s stock price fell by one-third.

March 31, 2026

·

2 min read

·

Tristan Manalac

Immunology and inflammation

AAD 2026: Sanofi, Incyte, Roivant and Alumis Make Headway Into Skin Diseases

Presentations at the 2026 meeting of the American Academy of Dermatology not only demonstrate the therapeutic potential of next-generation skin drugs but also shed light on how they might fare on the market.

March 31, 2026

·

4 min read

·

Tristan Manalac

Press Releases

SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

March 31, 2026

·

7 min read

Press Releases

SCYNEXIS Announces $40.0 Million Private Placement